share_log
Breakings ·  Jun 1 04:05
Immunocore - Monotherapy Brenetafusp in Late-Line Cutaneous Melanoma Demonstrated Promising Progression Free Survival and Ctdna Molecular Response
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment